Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Telomere Length and Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

    ... bone marrow engraftment or incidence of graft-versus-host disease (GVHD) .   In the same issue of this journal, an editorial by ...

    Research Review last updated 05/02/2016 - 9:13am.

  2. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... mycophenolate mofetil work in preventing graft versus host disease (GvHD) in patients with hematologic malignancies undergoing ... stem cell transplant may be better in preventing graft-versus-host disease. Status:  ...

    Clinical Trial last updated 05/03/2016 - 11:35am.

  3. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

    ... Wed, 02/01/2017 Bone Marrow Disease(s):  myelodysplastic syndromes (MDS) ... criteria and tacrolimus, for treatment or prophylaxis of graft-versus-host disease (GVHD) . If the patient has been on ...

    Clinical Trial last updated 06/06/2016 - 2:11pm.

  4. FAQs

    ... Disease This section answers the most ... These problems can include serious infections and graft-versus-host disease (GVHD) , in which the transplanted cells attack ...

    Topic section last updated 03/02/2016 - 11:42am.

  5. Transplantation Update

    ... Stem Cells Our view is that patients with non-malignant disease such as aplastic anemia, should receive stem cells from bone marrow ... is truly suited for stem cell transplantation is needed. Graft-Versus-Host Disease GVHD is still an issue, but can be less severe ...

    Interview last updated 05/14/2015 - 2:42pm.

  6. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... blood stem cell transplant works in preventing graft-versus-host disease in younger patients with high risk hematologic malignancies. Giving ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  7. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... complications, like severe infections and a condition called graft-versus-host disease, which is caused when cells from the donor attack the normal tissue of ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  8. CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    ... an immune response against the body's normal cells (called graft-versus-host disease). Giving cyclosporine and mycophenolate mofetil after the ...

    Clinical Trial last updated 04/29/2016 - 12:36pm.

  9. Clone of Patients

    ... Learn About Your Disease Once the initial shock ... to do is learn as much as possible about your life-changing disease. Knowledge is power, and learning about what’s happening to your body ...

    Page last updated 03/14/2016 - 6:05pm.

  10. Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerou

    ... mortality at day 100. III. Incidence and severity of graft-versus-host disease (GHVD). IV. Immune reconstitution. V. Infections during the ...

    Clinical Trial last updated 04/26/2016 - 2:09pm.